Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families

• Carlos Cruchaga ,

  * E-mail: cruchagc@psychiatry.wustl.edu (CC); goatea@psychiatry.wustl.edu (AMG)

  Affiliation Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Sumitra Chakraverty,

  Affiliation Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Kevin Mayo,

  Affiliation Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Francesco L. M. Vallania,

  Affiliation Department of Genetics, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Robi D. Mitra,

  Affiliation Department of Genetics, Washington University, St. Louis, Missouri, United States of America

  ⨯
• Kelley Faber,

  Affiliation Department of Medical and Molecular Genetics, Indiana University, Indianapolis, United States of America

  ⨯
• Jennifer Williamson,

  Affiliation Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, New York, United States of America

  ⨯
• Tom Bird,

  Affiliation VA Medical Center and Departments of Neurology and Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Ramon Diaz-Arrastia,

  Affiliation Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America

  ⨯
• Tatiana M. Foroud,

  Affiliation Department of Medical and Molecular Genetics, Indiana University, Indianapolis, United States of America

  ⨯
• Bradley F. Boeve,

  Affiliation Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Neill R. Graff-Radford,

  Affiliation Department of Neurology, Mayo Clinic, Jacksonville, Florida, United States of America

  ⨯
• Pamela St. Jean,

  Affiliation Genetics, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Michael Lawson,

  Affiliation Genetics, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Margaret G. Ehm,

  Affiliation Genetics, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Richard Mayeux,

  Affiliation Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University College of Physicians and Surgeons, New York, New York, United States of America

  ⨯
• Alison M. Goate ,

  * E-mail: cruchagc@psychiatry.wustl.edu (CC); goatea@psychiatry.wustl.edu (AMG)

  Affiliations Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, Washington University, St. Louis, Missouri, United States of America, Department of Genetics, Washington University, St. Louis, Missouri, United States of America

  ⨯
•  [ ... ],
• for the NIA-LOAD/NCRAD Family Study Consortium
• [ view all ]
• [ view less ]